Cardiff Oncology (CRDF) Revenue & Revenue Breakdown
Cardiff Oncology Revenue Highlights
Latest Revenue (Y)
$488.00K
Latest Revenue (Q)
$165.00K
Main Segment (Y)
Royalty
Main Geography (Y)
Royalty
Cardiff Oncology Revenue by Period
Cardiff Oncology Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $488.00K | 26.42% |
2022-12-31 | $386.00K | 7.52% |
2021-12-31 | $359.00K | -1.91% |
2020-12-31 | $365.99K | 49.38% |
2019-12-31 | $245.00K | -35.19% |
2018-12-31 | $378.00K | -25.15% |
2017-12-31 | $505.00K | 32.55% |
2016-12-31 | $381.00K | 21.73% |
2015-12-31 | $313.00K | 11.79% |
2014-12-31 | $280.00K | 8.01% |
2013-12-31 | $259.25K | -42.39% |
2012-12-31 | $450.00K | 74.62% |
2011-12-31 | $257.70K | -3.00% |
2010-12-31 | $265.67K | -59.13% |
2009-12-31 | $650.00K | 100.00% |
2006-01-31 | - | 100.00% |
2005-01-31 | - | - |
Cardiff Oncology Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $165.00K | 1.23% |
2024-06-30 | $163.00K | -20.49% |
2024-03-31 | $205.00K | 31.41% |
2023-12-31 | $156.00K | 10.64% |
2023-09-30 | $141.00K | 30.56% |
2023-06-30 | $108.00K | 30.12% |
2023-03-31 | $83.00K | -35.16% |
2022-12-31 | $128.00K | 37.63% |
2022-09-30 | $93.00K | 2.20% |
2022-06-30 | $91.00K | 22.97% |
2022-03-31 | $74.00K | -44.36% |
2021-12-31 | $133.00K | 54.65% |
2021-09-30 | $86.00K | 26.47% |
2021-06-30 | $68.00K | -5.56% |
2021-03-31 | $72.00K | -39.63% |
2020-12-31 | $119.25K | -12.57% |
2020-09-30 | $136.40K | 219.94% |
2020-06-30 | $42.63K | -37.03% |
2020-03-31 | $67.70K | -27.20% |
2019-12-31 | $93.00K | 79.93% |
2019-09-30 | $51.69K | -62.55% |
2019-06-30 | $138.00K | -14.81% |
2019-03-31 | $162.00K | 107.69% |
2018-12-31 | $78.00K | -11.73% |
2018-09-30 | $88.36K | -20.97% |
2018-06-30 | $111.81K | 11.66% |
2018-03-31 | $100.14K | -45.87% |
2017-12-31 | $185.00K | 50.01% |
2017-09-30 | $123.33K | 20.90% |
2017-06-30 | $102.01K | 7.34% |
2017-03-31 | $95.04K | 39.76% |
2016-12-31 | $68.00K | -23.69% |
2016-09-30 | $89.11K | -13.82% |
2016-06-30 | $103.40K | -14.18% |
2016-03-31 | $120.49K | 52.19% |
2015-12-31 | $79.17K | 38.10% |
2015-09-30 | $57.33K | 16.17% |
2015-06-30 | $49.35K | -61.14% |
2015-03-31 | $126.97K | 125.13% |
2014-12-31 | $56.40K | -1.40% |
2014-09-30 | $57.20K | 2.82% |
2014-06-30 | $55.63K | -49.86% |
2014-03-31 | $110.95K | 134.24% |
2013-12-31 | $47.37K | 8.25% |
2013-09-30 | $43.76K | -10.70% |
2013-06-30 | $49.00K | -58.87% |
2013-03-31 | $119.12K | -27.03% |
2012-12-31 | $163.25K | -22.81% |
2012-09-30 | $211.50K | 409.64% |
2012-06-30 | $41.50K | 21.51% |
2012-03-31 | $34.15K | 1.19% |
2011-12-31 | $33.75K | -38.64% |
2011-09-30 | $55.00K | -31.13% |
2011-06-30 | $79.86K | -10.35% |
2011-03-31 | $89.08K | -57.58% |
2010-12-31 | $210.00K | 600.00% |
2010-09-30 | $30.00K | 50.00% |
2010-06-30 | $20.00K | 100.00% |
2010-03-31 | - | - |
Cardiff Oncology Revenue Breakdown
Cardiff Oncology Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 20 | Dec 19 |
---|---|---|
Royalty | $365.99K | $243.14K |
Service | - | $1.50K |
Latest
Quarterly Revenue by Product
Product/Service | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|
Royalty | $92.58K | $51.69K | $36.85K |
Service | - | - | $101.43K |
Latest
Cardiff Oncology Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 20 | Dec 19 |
---|---|---|
Royalty | $365.99K | $243.14K |
Service | - | $1.50K |
Latest
Quarterly Revenue by Country
Country | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|
Royalty | $92.58K | $51.69K | $36.85K |
Service | - | - | $101.43K |
Latest
Cardiff Oncology Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MREO | Mereo BioPharma Group | $10.00M | - |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
CUE | Cue Biopharma | $5.49M | $3.34M |
AUTL | Autolus Therapeutics | $1.70M | - |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
CRDF | Cardiff Oncology | $488.00K | $165.00K |
EYEN | Eyenovia | $3.79K | $1.63K |
NLSP | NLS Pharmaceutics | - | - |
CGEM | Cullinan Oncology | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
INAB | IN8bio | - | - |
CGTX | Cognition Therapeutics | - | - |
KOD | Kodiak Sciences | - | - |
LTRN | Lantern Pharma | - | - |
SLS | SELLAS Life Sciences Group | - | - |
RNAZ | TransCode Therapeutics | - | - |